Format

Send to

Choose Destination
Immunity. 2010 Apr 23;32(4):468-78. doi: 10.1016/j.immuni.2010.03.018.

Prediction and pathogenesis in type 1 diabetes.

Author information

1
Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Kölner Platz 1, 80804 München, Germany. anziegler@lrz.uni-muenchen.de

Abstract

A combination of genetic and immunological features is useful for prediction of autoimmune diabetes. Patterns of immune response correspond to the progression from a preclinical phase of disease to end-stage islet damage, with biomarkers indicating transition from susceptibility to active autoimmunity, and to a final loss of immune regulation. Here, we review the markers that provide evidence for immunological checkpoint failure and that also provide tools for assessment of individualized disease risk. When viewed in the context of genetic variation that influences immune response thresholds, progression from susceptibility to overt disease displays predictable modalities of clinical presentation resulting from a sequential series of failed homeostatic checkpoints for selection and activation of immunity.

PMID:
20412757
PMCID:
PMC2861716
DOI:
10.1016/j.immuni.2010.03.018
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center